Whole Exome Sequencing and Other Emerging Technologies of Endoscopic Ultrasound Cytopathology


About this study

The purpose of this research study is to gather information on the feasibility of performing novel molecular analysis on Endoscopic Ultrasound acquired cytologic material and to assess molecular changes in cytology samples to see if that may aid treatment decision planning for future patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients with a clinically suspicious mass requiring a routine clinical EUS FNA for diagnostic and staging purposes

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Ferga Gleeson, M.B., B.Ch.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer